×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Featured
Want to learn more about 10th Annual Meeting DIA Japan 2013? You've come to the right site!
Program Committee
-
Yasushi Saito, MD, PhD President
Chiba University Hospital, Japan -
Koichi Miyazaki, PhD Senior Director, Group IV, Oncology Clinical Development Department
Daiichi Sankyo Co., Ltd., Japan -
Koji Ando Director
Quintiles Transnational Japan K.K., Japan -
Kasumi Daidoji, PhD, RPh Associate Director, Clinical Planning & Development Dept., Medical Headquarters
Eisai Co., Ltd., Japan -
Satoru Fukinbara, PhD Senior Director, Data Science Development Headquarters
Ono Pharmaceutical Co., Ltd., Japan -
Hirotaka Inoue, PhD, MBA Head, Leading Changes Office, Japan Development & Medical Affairs Division
GlaxoSmithKline K.K., Japan -
Junichi Koga, MD, PhD, PMP Senior Executive Officer and Global Head of R&D
Daiichi Sankyo, United States -
Yoshiko Komuro, PhD Inspection Director, Office of Non-Clinical and Clinical Compliance
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Koichi Konno, PMP Manager
PM lab. Positive Intention, Japan -
Rei Maeda Consultant
Independent Consultant for Drug PV, Japan -
Toshio Maruyama Manager (CMC), Regulatory Affairs Dept 2, Development & Medical Affairs Div
GlaxoSmithKline K.K., Japan -
Yoshihiro Matsuda, PhD Senior Scientist (for Quality), Pharmacist
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Moriyuki Miyasato, MBA Corporate Officer, Head of Data Science Division
CMIC Co., Ltd., Japan -
Takashi Moritoyo, MD, PhD Professor, Head of Clinical Recerch Promotion Center
The University of Tokyo Hospital, Japan -
Fumitaka Nagamura, MD, PhD Professor
The University of Tokyo, Japan -
Kenji Nagaya Project Manager, Clinical Research Center
Nagoya Medical Center, Japan -
Nobumasa Nakashima Health Policy Director, National Healthcare Policy Secretariat
Cabinet Office, Japan -
Hiroshi Negishi Regulatory Scientist, Therapeutic Area Regulatory
Eli Lilly Japan K.K., Japan -
Junichi Nishino, MSc, RPh Head, Regulatory Affairs Department
Otsuka Pharmaceutical Co., Ltd., Japan -
Takuya Oshida, PharmD, MSc Senior Vice President, Head of Medical Affairs, Japan, Medical Affairs Japan
Astellas Pharma Inc., Japan -
Shinichi Tsuchiwata, MS Manager, Clinical Pharmacology
Pfizer R&D Japan G.K., Japan -
Atsushi Tsukamoto, PhD, MSc Corporate Officer, Head is Therapeutic Area Strategies
Daiichi Sankyo, United States -
Satoko Utsunomiya Regulatory Affairs Area, Japan Development
MSD K.K., Japan -
Yoshiaki Uyama, PhD, RPh Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Takeharu Yamanaka, PhD Professor, Department of Biostatics, School of Medicine
Yokohama City University, Japan -
Manabu Yanagisawa, PhD Director, Global Scientific and Regulatory Affairs
Japan Pharmaceutical Manufacturers Association, Japan -
Norie Miki-Yasuda, PhD Head of Clinical Operations Europe, Canada, Australia & New Zealand
Boehringer Ingelheim Pharma GmbH & Co. KG, Germany -
Hideki Hanaoka, MD, PhD Doctor
Chiba University Hospital, Japan -
Hironobu Saito, PhD Specially Appointed Professor
Tottori University, Chromosome Egineering Research Center, Japan
Have an account?